ARGININE

Fragrance Ingredient; Hair Conditioning Agent; Skin-Conditioning Agent - Miscellaneous; ANTISTATIC; MASKING; SKIN CONDITIONING  

Also listed as

L-A-AMINO-D -GUANIDINOVALERIC ACID; L-ARGININE; L-ORNITHINE, N5- (AMINOIMINOMETHYL) -; N5- (AMINOIMINOMETHYL) - L-ORNITHINE; (L) -ARGININE; L- (+) -ARGININE; L-ARGININE; L-ORNITHINE, N5- (AMINOIMINOMETHYL) -


Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to this ingredient -- not the products containing it -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.

This ingredient:
yes, weakCancer
yes, weakDevelopmental/reproductive toxicity
noViolations, restrictions & warnings
noAllergies/immunotoxicity
noContamination concerns
noOther moderate concerns for this ingredient:
Neurotoxicity, Organ system toxicity (non-reproductive)
noLesser or emerging concerns for this ingredient:
Endocrine disruption, Data gaps, Biochemical or cellular level changes
 
See products containing ARGININE

About ARGININE: Arginine is the amino acid.

ARGININE has reported used in the following product types: facial moisturizer/treatment (152); anti-aging (103); conditioner (85); shampoo (68); moisturizer (55); facial cleanser (34); sunscreen: SPF 15-30 (31); acne treatment (30); around-eye cream (27); sunscreen: makeup (25)


Neurotoxicity

type of concern product conditions reference
One or more animal studies show brain and nervous system effects at very low doses    RTECS®- Brazilian Journal of Medical and Biological Research 2003
show more

Organ system toxicity (non-reproductive)

type of concern product conditions reference
One or more animal studies show cardiovascular effects at very low doses    RTECS®- British Journal of Pharmacology 2003
show more

Cancer

type of concern product conditions reference
One or more in vitro tests on mammalian cells show positive mutation results    RTECS®- Mutation Research 1996
show more

Endocrine disruption

type of concern product conditions reference
One or more animal studies show endocrine disruption at moderate doses    RTECS®- Toxicology and Applied Pharmacology 2004

Developmental/reproductive toxicity

type of concern product conditions reference
One or more animal studies show reproductive effects at moderate doses    RTECS®- Toxicology and Applied Pharmacology 2004
show more

Biochemical or cellular level changes

type of concern product conditions reference
One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood    RTECS®- Journal of Korean Medical Science 2002
show more

Data gaps

type of concern product conditions reference
Not assessed for safety in cosmetics by industry panel  
17,296 studies on toxicity in PubMed see search results ->   PubMed

Persistence and bioaccumulation

type of concern product conditions reference
Not suspected to be persistent     Environmental Canada Domestic Substance List
show more

Multiple, additive exposure sources

type of concern product conditions reference
Designated as safe for general or specific, limited use in food   FDA Food Additive Status
Designated as safe for general or specific, limited use in food   FDA Everything Added to Food

Ecotoxicology

type of concern product conditions reference
Not suspected to be an environmental toxin     Environmental Canada Domestic Substance List



Government, industry, academic studies and classifications

government/industry list/academic study appears on list as classification(s)
FDA Food Additive StatusARGININE (L FORM ONLY)• NUTR/DS
• Food additive: food additive for which a petition has been filed and a regulation issued - CFR172.320
FDA Everything Added to FoodL-ARGININE• Fully up-to-date toxicology information has been sought.
Environmental Canada Domestic Substance ListL-ARGININE•This chemical was NOT flagged by CEPA for further attention.
RTECS®- Brazilian Journal of Medical and Biological Research 2003ARGININE• brain and nervous system - Analgesia (rat TDLo)
RTECS®- Brazilian Journal of Medical and Biological Research 2003ARGININE• cardiovascular - BP lowering not characterized in autonomic section (rat TDLo)
• kidney or renal system - Other changes in urine composition (rat TDLo)
• kidney or renal system - Urine volume increased (rat TDLo)
RTECS®- British Journal of Pharmacology 2003ARGININE• cardiovascular - BP lowering not characterized in autonomic section (rat TDLo)
• cardiovascular - Change in rate (rat TDLo)
RTECS®- Clinical and Experimental Pharmacology and Physiology 2000ARGININE• cardiovascular - BP lowering not characterized in autonomic section (rat TDLo)
• kidney or renal system - Other changes in urine composition (rat TDLo)
• kidney or renal system - Urine volume increased (rat TDLo)
RTECS®- Clinical and Experimental Pharmacology and Physiology 2001ARGININE• metabolic - Na (rat TDLo)
• cardiovascular - BP lowering not characterized in autonomic section (rat TDLo)
• kidney or renal system - Urine volume increased (rat TDLo)
RTECS®- Clinical and Experimental Pharmacology and Physiology 2002ARGININE• kidney or renal system - Changes in blood vessels or in circulation of kidney (rat TDLo)
• cardiovascular - BP lowering not characterized in autonomic section (rat TDLo)
• kidney or renal system - Urine volume increased (rat TDLo)
RTECS®- European Journal of Pharmacology 2004ARGININE• biochemical - Other (rabbit TDLo)
• cardiovascular - Other changes (rabbit TDLo)
RTECS®- Indian Journal of Experimental Biology 1986ARGININE• mutagenic - Positive mutation assay: Cytogenetic Analysis (grasshopper par)
RTECS®- Indian Journal of Experimental Biology 1986ARGININE• mutagenic - Positive mutation assay: Cytogenetic Analysis (grasshopper par)
RTECS®- Journal of Applied Toxicology (John Wiley & Sons, Ltd 2004ARGININE• biochemical - Catalases (rat TDLo)
• blood - Changes in serum composition (eg., TP, bilirubin, cholesterol) (rat TDLo)
• biochemical - Isomerases (rat TDLo)
• liver - Other changes (rat TDLo)
RTECS®- Journal of Korean Medical Science 2002ARGININE• biochemical - Catalases (rat TDLo)
• biochemical - Lipids, including transport (rat TDLo)
• liver - Other changes (rat TDLo)
RTECS®- Journal of Korean Medical Science 2003ARGININE• blood - Changes in serum composition (eg., TP, bilirubin, cholesterol) (rat TDLo)
• gastrointestinal - Changes in structure or function of endocrine pancreas (rat TDLo)
• biochemical - Other hydrolases (rat TDLo)
RTECS®- Journal of Pharmacology and Experimental Therapeutics 2001ARGININE• biochemical - Effect on inflammation or mediation of inflammation (rat TDLo)
• biochemical - Other proteins (rat TDLo)
• cardiovascular - Structural changes in vessels (rat TDLo)
RTECS®- Mutation Research 1996ARGININE• mutagenic - Positive mutation assay: Sister Chromatid Exchange ( human lym)
RTECS®- Mutation Research 1996ARGININE• mutagenic - Positive mutation assay: Sister Chromatid Exchange ( human lym)
RTECS®- Psychopharmacology (Berlin) 2003ARGININE• brain and nervous system - Alteration of operant conditioning (mouse TDLo)
RTECS®- Psychopharmacology (Berlin) 2004ARGININE• brain and nervous system - Changes in motor activity (specific assay) (rat TDLo)
RTECS®- Psychopharmacology (Berlin) 2005ARGININE• brain and nervous system - Changes in motor activity (specific assay) (mouse TDLo)
RTECS®- Toxicology and Applied Pharmacology 2004ARGININE• reproductive - Fetotoxicity (rat TDLo)
RTECS®- Toxicology and Applied Pharmacology 2004ARGININE• reproductive - Post-implantation mortality (rat TDLo)
• reproductive - Prostate, seminal vesicle, Cowper's gland, accessory glands (rat TDLo)
• reproductive - Testes, epididymis, sperm duct (rat TDLo)
• endocrine system - Changes in testicular weight (rat TDLo)
RTECS®- Toxicology 2005ARGININE• cardiovascular - BP lowering not characterized in autonomic section (rat TDLo)
• blood - Changes in serum composition (eg., TP, bilirubin, cholesterol) (rat TDLo)
• kidney or renal system - Other changes (rat TDLo)

references

government/industry list/academic study reference
FDA Food Additive StatusFDA (U.S. Food and Drug Administration) 2006. Food Additive Status List. Downloaded from http://www.cfsan.fda.gov/%7Edms/opa-appa.html, Oct 16, 2006.
FDA Everything Added to FoodFDA (U.S. Food and Drug Administration). 2008. EAFUS [Everything Added to Food]: A Food Additive Database. FDA Office of Food Safety and Applied Nutrition.
Environmental Canada Domestic Substance ListEC (Environment Canada). 2008. Domestic Substances List Categorization. Canadian Environmental Protection Act (CEPA) Environmental Registry.
RTECS®- Brazilian Journal of Medical and Biological Research 2003RTECS®- Brazilian Journal of Medical and Biological Research. (Associacao Brasileira de Divulgacao Cientifica, Faculdade de Medicina de Ribeirao Preto, USP, 141000 Ribeirao Preto, SP, Brazil) V.14- 1981- 36,1701,2003
RTECS®- Brazilian Journal of Medical and Biological Research 2003RTECS®- Brazilian Journal of Medical and Biological Research. (Associacao Brasileira de Divulgacao Cientifica, Faculdade de Medicina de Ribeirao Preto, USP, 141000 Ribeirao Preto, SP, Brazil) V.14- 1981- 36,943,2003
RTECS®- British Journal of Pharmacology 2003RTECS®- British Journal of Pharmacology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.34- 1968- 138,584,2003
RTECS®- Clinical and Experimental Pharmacology and Physiology 2000RTECS®- Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- 27,18,2000
RTECS®- Clinical and Experimental Pharmacology and Physiology 2001RTECS®- Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- 28,528,2001
RTECS®- Clinical and Experimental Pharmacology and Physiology 2002RTECS®- Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- 29,772,2002
RTECS®- European Journal of Pharmacology 2004RTECS®- European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- 492,211,2004
RTECS®- Indian Journal of Experimental Biology 1986RTECS®- Indian Journal of Experimental Biology. (Publications & Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- 24,460,1986
RTECS®- Indian Journal of Experimental Biology 1986RTECS®- Indian Journal of Experimental Biology. (Publications & Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 24,460,1986
RTECS®- Journal of Applied Toxicology (John Wiley & Sons, Ltd 2004RTECS®- Journal of Applied Toxicology (John Wiley & Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- 24,93,2004
RTECS®- Journal of Korean Medical Science 2002RTECS®- Journal of Korean Medical Science. (Korean Academy of Medical Science, C.P.O. Box 2062, Seoul, S. Korea) V.1- 1986- 17,502,2002
RTECS®- Journal of Korean Medical Science 2003RTECS®- Journal of Korean Medical Science. (Korean Academy of Medical Science, C.P.O. Box 2062, Seoul, S. Korea) V.1- 1986- 18,520,2003
RTECS®- Journal of Pharmacology and Experimental Therapeutics 2001RTECS®- Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- 299,832,2001
RTECS®- Mutation Research 1996RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 372,75,1996
RTECS®- Mutation Research 1996RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 372,75,1996
RTECS®- Psychopharmacology (Berlin) 2003RTECS®- Psychopharmacology (Berlin). (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.47- 1976- 167,291,2003
RTECS®- Psychopharmacology (Berlin) 2004RTECS®- Psychopharmacology (Berlin). (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.47- 1976- 176,435,2004
RTECS®- Psychopharmacology (Berlin) 2005RTECS®- Psychopharmacology (Berlin). (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.47- 1976- 178,500,2005
RTECS®- Toxicology and Applied Pharmacology 2004RTECS®- Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- 197,197,2004
RTECS®- Toxicology and Applied Pharmacology 2004RTECS®- Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- 197,351,2004
RTECS®- Toxicology 2005RTECS®- Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- 207,463,2005

"RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through MDL Information Systems, Inc.

Favorites basket

No items in basket.

Skin Deep User Tools BETA

Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.

SKIN DEEP NEEDS YOUR HELP

We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.

Support EWG

WANT TO KNOW MORE?

Stay informed with email updates on toxics in everyday products and how they can affect your health.

[Privacy policy]

 

JOIN THE CAMPAIGN

Find out more about the Campaign for Safe Cosmetics.